But Mr. Rennert’s privately held industrial empire includes the smelter with a towering smokestack that overlooks Ms. Albino’s home, so the health and economic fate of her and thousands of others here rest on the corporate maneuvers he is carrying out.

La Oroya has been called one of the world’s 10 most polluted places by the Blacksmith Institute, a nonprofit group that studies toxic sites. But for several months, the Peruvian smelting company in Mr. Rennert’s empire has claimed that low metals prices prevented it from completing a timely cleanup to lower the emissions that have given this town such an ignoble distinction.

The tensions here over the lead emissions and the smelter’s financial meltdown is precisely the kind of dire mix of foreign investment and environmental contamination feared by indigenous groups elsewhere in Peru, particularly in the country’s Amazon basin, where protests over similar issues left dozens dead this month.

Citing financial difficulties, the smelter’s Peruvian operators, who have idled most of its operations, have threatened to close entirely for several months, putting in danger 3,000 jobs at the plant and thousands more who rely on it like Ms. Albino, who washes clothes for the wives of smelter workers.

This week, some workers and residents protested against the possible closing, halting traffic and commerce along the highway that descends from La Oroya to the capital, Lima. Then on Tuesday, the government signaled that it might be open to extending the October deadline for the cleanup. Officials involved in talks on Wednesday said that one possible solution to the impasse would involve giving workers some control of the plant.

“This man Rennert, I’ve heard of him on television, of his great wealth and the homes he has around the world,” said Ms. Albino. “As for me, I cannot afford to test the lead levels in my daughters’ blood any longer,” she said, attributing the stunted growth of her youngest daughter, 7, to the smelter’s emissions.

Residents of La Oroya, with a population of 35,000, talk about the lead in their blood like people elsewhere discuss the weather. Ninety-seven percent of children under the age of 6 had lead levels that would be considered toxic by the Centers for Disease Control and Prevention in the United States, according to a 2005 study by scientists from Saint Louis University.

But while some here seethe against Mr. Rennert and the company, Doe Run Peru, others defend them for providing work, making for a sharply divided town.

“We are thankful to Doe Run,” said Elizabeth Canales, 40, a seamstress and a member of a company-supported group that teaches hygiene to poor families here. “It truly saddens me because I don’t know if this is happening because there’s a misunderstanding.”

Some publicly praise Doe Run Peru while requesting, amid fear of retribution, anonymity to vent their anger at the company. “This town is owned by one company, and we vassals cannot be seen as disloyal to our owners,” said one longtime worker.

The discord between those for and against the company festers in La Oroya’s labyrinthine streets, packed with stands selling foods like seasoned guinea pig and bars catering to the plant’s workers, who largely move here from other parts of Peru and earn salaries that dwarf those of other residents.

Insults and threats are common. Some workers at the plant recently paraded an effigy of Archbishop Pedro Barreto, an outspoken critic of the company’s environmental record, burning it at the culmination of their protest.

“When insults don’t work, the company resorts to intimidation, and when that fails, to blackmail, which is what it’s doing now by saying it will shut the plant unless it gets an extension for its cleanup,” said Pedro Córdova, 50, a production mechanic at the smelter who is suing the company over health claims related to a lung ailment.

Environmental activists in La Oroya said they saw parallels between Doe Run Peru’s strategies here and those employed elsewhere by Renco, Mr. Rennert’s holding company. Even as his fortune remained intact, they contend, some Renco companies in the United States faced complaints over environmental contamination and went into bankruptcy earlier this decade.

Through a spokesman in New York, Mr. Rennert declined to be interviewed, and Renco would say only that it was in talks aimed at “reaching a viable solution.”

Doe Run Peru claims that it has “dramatically reduced” the toxic emissions at the smelter since buying it from Peru’s government in 1997, leading to “a radical improvement in environmental conditions.”

Still, researchers contend Doe Run Peru has misled officials by using 1997, the year it took control of the smelter, as a point of comparison for pollution levels, since contamination climbed that year. “Doe Run Peru has overseen an absolute increase in contamination in La Oroya,” said Corey Laplante, an American scholar who researched La Oroya at the Peruvian Society for Environmental Law in Lima.

Despite being pressed by workers here to find a solution, officials in Lima this week said they had concerns about taking over or intervening in the company, pointing to legal battles that could arise from taking some control of a foreign-owned asset.

News reports that Renco had tried this month to buy the Swedish automaker Saab, led angry residents here to ask why Doe Run Peru could not complete its cleanup or prevent a shutdown of the smelter at a time when metal prices have begun to climb again.

Nearly everyone here wants the smelter to remain open and for the cleanup to proceed. But with Peru forging closer ties to the United States in Latin America through its new trade deal with Washington, some here question the benefits of such a pact.

The official box packaging of Windows 7…

Free Upgrades

If you buy a PC starting Friday, June 26th, it should be covered under a free upgrade plan. (I say “should” because it depends on the manufacturer, but most of them are jumping on this with both feet.) Say you buy a computer with Vista Home Premium this weekend; you get a Windows 7 Home Premium upgrade on October 22, free. If you buy Vista Business, you’ll get Win 7 Professional, and if you buy Vista Ultimate, you’ll get Win 7 Ultimate. There’s no upgrade path for Home Basic (the reason is below) but as I understand it, the number of systems sold at retail with Home Basic on it are in the low single digits.

That should take care of most PC buyers.

The Half-Price Pre-Order Deal

People in the US, Canada or Japan who already own a PC running XP or Vista will be able to pre-order the upgrade disc at around half the price that they’ll eventually sell for. The pre-order deal also starts Friday, June 26th, and will run for a limited time.

As I said, Windows 7 Home Premium, usually $120, will cost $50, and Windows 7 Professional, usually $200, will cost $100. Windows 7 Ultimate is not part of this discount plan, but it might get its own incentive plan later on. (You could technically buy Home Premium upgrade, then pay to convert it to Ultimate, saving at least a little cash.) The pre-order deal will be visible at store.microsoft.com and at “most major retailers.”

What’s this about a limited time? Mike Ybarra, general manager of Windows Product Management, told me that the pre-order deal will go away when a certain undisclosed number of licenses is sold. “We have enough quantity,” he said, adding that the magic number was “equivalent to a year of Vista sales volume at retail.” (Ironically, those of you who want this upgrade offer to last have to hope that the Mojave Experiment worked, at least a little.) Some Microsoft materials suggest that July 11th might be the cutoff for the deal, but from what I understand, that’s an estimate—this is based on supply. Regardless, if you want Windows 7, pre-order the damn thing come Friday.

European Hijinks

Europe is getting kinda screwed in this deal, because of the European Commission’s banning of IE8 from any Windows installer media. Basically, starting July 15th in France, Germany and the UK, Microsoft will be selling full versions of Windows 7 Home Premium and Professional at the discounted upgrade prices, but that means there’s no way to upgrade directly from Vista.

Euros who buy Win 7 will be forced to perform a clean install, and migrate their data and apps over any way they know how. The logic is that, while the Windows team can do a clean install without IE8, there’s not enough quality assurance on what an upgrade install would be like without IE8, with assorted HTML rendering apps co-existing in the OS already. Could be messy, says Ybarra. “We don’t want to break anyone else’s software, we don’t want to break our own software, and we don’t want the customer on the phone with support.” That funky deal is supposed to run through December.

The Official Prices

So, now that we got the immediate realities out of the way, here are the “estimated retail prices” that we’ll eventually see in stores, for the people who aren’t yet moving on the upgrade offers:

Windows 7 Home Premium: $120 for upgrade; $200 for full version
Windows 7 Professional: $200 for upgrade; $300 for full version
Windows 7 Ultimate: $220 for upgrade; $320 for full version

To be clear, the term “upgrade” just means you already own and run a version of Windows on the PC you’re upgrading. It’s still a complete set of bits that you can clean install and even set up for dual booting. The “full” version is mostly for people who are building their own systems.

You may remember that there are other Win 7 SKUs such as Home Basic and Starter. Windows 7 Home Basic is not available in the United States or most of Europe though, along with residents of Burkina Faso and Vanuatu, Montenegrans will be able to buy it.

Windows 7 Starter will be offered to Dell, HP, Asus and other manufacturers to stick on netbooks. Just in case you were concerned, Windows XP will also be available, distributed and supported for 12 months after Windows 7 launches though limited to these same “small notebook PCs.” I think Microsoft—and quite a few non-vested-interests—are expecting netbooks to ditch XP for Win 7 pretty fast.

When You Actually Get It

Cannabis Science Inc., President & CEO, Steven W. Kubby said, “We have the science and preliminary anecdotal results confirming the anti-inflammatory properties of our new lozenges and indicating they may present an effective and non-toxic treatment for minimizing the symptoms and harm from influenza infections. Our lozenges appear to down-regulate the body’s excessive inflammatory response to the influenza virus, which could reduce the deadly consequences of an infection into something that is more like a common cold. Because of my cancer and diminished auto-immune functions, even common influenza is a deadly threat, and I’ve had incredible symptomatic relief with the lozenge.”

Dr. Robert J. Melamede, Director and Chief Science Officer, stated, “The influenza virus has a unique genetic make up that, in combination with its replicative machinery, has an extraordinary capacity to mutate. As a result, the high lethality of some strains can be attributed to the resulting adult respiratory distress syndrome (ARDS). ARDS is caused by an excessive immune inflammatory response driven by Tumor Necrosis Factor (TNF) that leads to the death of respiratory epithelial cells and resulting organ failure. Endocannabinoids are nature’s way of controlling TNF activity. Existing peer reviewed publications have shown that phytocannabinoids can prevent this cell death by mimicking the endocannabinoids that nature has selected to prevent excessive inflammatory immune responses.”

Dr. Melamede, who is also a researcher and past Chairman of the Biology Department at the University of Colorado Springs (UCCS), cautioned, “Smoked marijuana will not effectively prevent the excessive inflammatory response, despite delivering the beneficial pharmacological agents, due to the irritating, pro-inflammatory nature of smoke. In fact, I believe it will make things worse and should be avoided by infected individuals.”

Mr. Kubby added, “If a swine or bird flu pandemic emerges — and everyone seems to think that it is just a matter of when, not if –, there is simply no time for the usual bureaucratic process. With emergency government approval, we can legally access the huge supply of medical cannabis available in California to produce millions of life saving doses within a relatively short period of time.”

Dr. Melamede furthermore stated, “Based upon recent discoveries regarding the role that endocannabinoid system plays in maintaining human health, we have a unique solution to the looming threat posed by deadly influenza strains that we believe, if implemented, could save millions of lives. We will strive for an emergency review of our cannabis extract-based lozenge because we believe its availability will prevent many of the deaths associated with the hyper-inflammatory response associated with known lethal strains of the influenza virus. Current anti-influenza medications have a demonstrated decreased effectiveness against some of these lethal variants. Mankind cannot wait for the emergency situation to materialize. We must be proactive in gaining the necessary governmental approvals to test, and pending the outcome of our studies, produce our lozenge.”

Mr. Richard Cowan, Director and CFO, who recently spoke in Mexico City to a conference sponsored by the Mexican Congress, stated, “I believe the Mexican Congress recognizes that doctors should be able to prescribe medical cannabis. We are prepared to work with the government of Mexico to produce similar medical cannabis products to help fight the outbreak there. We look forward to working with Government officials, including Homeland Security, to help advance our treatments for these outbreaks in Mexico, Canada, the USA, and around the world.”

About the H5N1 Bird Flu and H1N1 Swine Flu Strains
The H5N1 bird flu currently has 63% lethality. A swine-derived H1N1 strain was responsible for 20,000,000 influenza associated deaths in 1918 (more than killed by World War I). The current lethal outbreak of swine flu (H1N1) in Mexico has killed over 80 people and infected more than 1,400 others. There are 20 confirmed cases in the United States, with reports of infections in Texas, New York, Ohio, California and Kansas. Additional reports identify possible cases in New Zealand, Canada, Spain, France and Israel. The H1N1 Swine flu is a porcine respiratory disease caused by type A flu viruses. Human cases occur in people who are around pigs, but an infected person can transmit the disease to another person. Symptoms include a high fever, body aches, coughing, sore throat and respiratory congestion.